Tag | Content |
---|
EnhancerAtlas ID | HS176-32686 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr5:125855320-125856350 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Myod1 | MA0499.1 | chr5:125855745-125855758 | AGAAACAGCTGCT | - | 6.28 | Tcf12 | MA0521.1 | chr5:125855748-125855759 | AACAGCTGCTG | + | 6.32 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_03955 | chr5:125855324-125856609 | Brain_Anterior_Caudate | SE_46783 | chr5:125855664-125856120 | Ovary |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH05I126518 | chr5 | 125853742 | 125856690 |
|
Enhancer Sequence | CTGGGGTTAC AGGTGTGAGC CACCATGCCC GGCCGAGCTT TAACATTTTT AATTCTCCCA 60 GGTAGCCATG AAATTCCTCC TTTGTTCCAT TAGTGTCCAC CTACTTCTAT ACAATTTATT 120 CACATCACCT CAAATATCGA GATTTCAACC CTCCAGGATT CTCAAGCAAC CAGACTCCTG 180 CAGAACCTGA TAGTTAAGGG AAAAAGAAGA AAACATCATT GGTGATAAAG GAACTTGTAA 240 GGCAAAAGTA AATCAAACAA CTATAAAGAG AAGTGCCAGA AAGACTAACT AGAAACACAA 300 CTTTTGGAGA TTTGCCAAAA AAAAAAAGCA TTCTGCTTTT CTGATGACCA AGCCTGATTC 360 TTTGTATGAA GGCTACTAAA GCAAAGGAGA AACAAGATCA TAAGAGAAAA ACAGCAGAAG 420 AGGTAAGAAA CAGCTGCTGC CGTGCAGAGG AAAAACACTG ACAGGCAGGG AGCCCAGCAG 480 CATTCATTTA GACAGCAGAA AAGAGAACAG AGCTGCTTTC CTGAGGGATC ATTCTCACTT 540 CTACCCACCC TGCAAGCACC AACACAAGAC CACTCCGTGT GGGGGCTGCC CTGAAGCTGG 600 CACAAGGCCT GGAGGCCAAC TAGTCCCACT GACACCTTTG GGAATGATCA GGATCAGAAT 660 ATGCCACCCC AAAATATGCC ACTTTGGCAA AGGATTGTGT TGAGCTGAAG GCAATTGAGA 720 AATAACAGAC TGCTGAAAAA GCTCTCTACC CTCCCCCATC TGCCTAAAAG CAGGACATAA 780 ATTTCTCTTT GTGAAGGCAC TTTTCTCTCC TCTCCCATAC CAGGAAAAAG AAACAATTCT 840 TATCACTGGA GATGCACTGG CTTGAATCTG CATAAATAAA CCTTGCTGAA ATAACCCTTA 900 TCTTTCATTA CCCATATATT TACCTTCCCA CAAGGTACGG TGCCTAGGAG ATCCAACTTC 960 TCCACAAATT TATCATCCTT TGTTAAAATG CTATATAAGT CTTTGGTCAC CTCTTTGGGG 1020 TTTTCATTTA 1030
|